Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2012
10/24/2012CN102743458A Formula of health drug with effects blood fat regulating and immunity increasing
10/24/2012CN102743455A Chinese patent medicine for treating diabetes mellitus
10/24/2012CN102743448A Compound traditional Chinese medicine for treating hyperlipidemia
10/24/2012CN102743416A Preparation method of nano-propolis solution
10/24/2012CN102743394A Composite fat-soluable vitamin injection
10/24/2012CN102743385A Modulators of atp-binding cassette-transporters
10/24/2012CN102743379A Composition containing eighteen amino acids
10/24/2012CN102743378A Composition containing 18 amino acids
10/24/2012CN102743370A Novel use of diacerein
10/24/2012CN102743368A Compounds for the treatment of metabolic disorders
10/24/2012CN102743354A Repaglinide tablet and preparation method thereof
10/24/2012CN102743350A Methionine-vitamin B1 composition injection
10/24/2012CN102743348A Small-size levocarnitine freeze-dried powder injection and preparation method and production device thereof
10/24/2012CN102743346A Small-size fat-soluble vitamin freeze-dried powder injection and preparation method and preparation device thereof
10/24/2012CN102743340A Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate
10/24/2012CN102743339A Alkaline phosphatase micro-/nano-particle and preparation method thereof
10/24/2012CN102743304A Compound essential oil with body building and shaping functions, and preparation method thereof
10/24/2012CN102742969A Weight losing shoe pad
10/24/2012CN102742968A Insole for curing endocrinopathy
10/24/2012CN102742699A Sweet osmanthus substitute tea
10/24/2012CN102274381B Chinese medicinal composition for reducing blood fat, protecting livers and relieving alcoholism and preparation method thereof
10/24/2012CN102271698B Pharmaceutical composition and use for preparing medicament thereof
10/24/2012CN102266308B Method for preparing odor masking sustained-release garlicin composite micro-capsules
10/24/2012CN102225070B Calcium carbonate effervescent granule
10/24/2012CN102133230B Compound mactra veneriformis organic calcium preparation and preparation method thereof
10/24/2012CN102099033B Pharmaceutical composition for treatment of fibromyalgia
10/24/2012CN101966171B Hydrosoluble reduced enzyme Q10 composition and preparation method thereof
10/24/2012CN101879221B Medical application of caulis polygoni multiflori
10/24/2012CN101668524B Pyrazole derivatives as 11-beta-hsd1 inhibitors
10/24/2012CN101337989B Novel glucagon-like peptide-1(GLP-1) analogues and use thereof
10/24/2012CN101317660B Method for improving soly solubility of monascus lovastatin in water and application thereof
10/24/2012CN101088487B polycondensate, preparation method thereof, cosmetic or drug composition, and use thereof
10/23/2012US8293755 Treatment of statin side effects using uridine derivatives
10/23/2012US8293751 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/23/2012US8293273 Controlled release and taste masking oral pharmaceutical composition
10/23/2012US8293223 Treatment of organ injuries and burns using placental stem cells
10/23/2012CA2693457C Inhibitors of 11b-hydroxysteroid dehydrogenase
10/23/2012CA2689659C Nitrogen-containing heterocyclic derivative having 11.beta.-hydroxysteroid dehydrogenase type 1 inhibitory activity
10/23/2012CA2547243C N-aryl piperidine substituted biphenylcarboxamides
10/23/2012CA2545584C Methods and compositions for the treatment of metabolic disorders
10/23/2012CA2537962C Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6 -enoicacid] calcium salt
10/23/2012CA2488635C Antagonists of melanin concentrating hormone receptor
10/23/2012CA2418802C Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
10/23/2012CA2359840C Glycosylated leptin compositions and related methods
10/18/2012WO2012141795A1 Protein hydrolysate compositions having enhanced cck and glp-1 releasing activity
10/18/2012WO2012141487A2 Cycloalkenyl aryl derivatives for cetp inhibitor
10/18/2012WO2012141316A1 Nutritional composition
10/18/2012WO2012141280A1 Dna vaccine
10/18/2012WO2012141160A1 Pitavastatin-containing preparation and method for producing same
10/18/2012WO2012141018A1 Composition, glucose metabolism-improving agent, and method for improving glucose metabolism
10/18/2012WO2012140894A1 Pharmaceutical composition
10/18/2012WO2012140597A1 Glycoside derivatives and their uses for the treatment of diabetes
10/18/2012WO2012140596A1 Glycoside derivatives and uses thereof
10/18/2012WO2012140298A1 Use of yessotoxins and the derivatives thereof for the treatment and/or prevention of metabolic diseases
10/18/2012WO2012139993A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012WO2012139524A1 Cb1 receptor inhibitor with low toxicity and optical activity and preparation method and use thereof
10/18/2012WO2012139499A1 Urea compounds as well as preparation methods, intermediates and uses thereof
10/18/2012WO2012139495A1 Mineralocorticoid receptor antagonists
10/18/2012WO2012091372A3 Caffeine tape for body slimming
10/18/2012US20120264966 Sulfur-containing phospholipid derivatives
10/18/2012US20120264834 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/18/2012US20120264826 N-Acetyl Beta Alanine Methods of Use
10/18/2012US20120264821 Use of equol for treating androgen mediated diseases
10/18/2012US20120264816 Sulfated Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Proliferation
10/18/2012US20120264812 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
10/18/2012US20120264797 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/18/2012US20120264791 Fatty acid niacin conjugates and their uses
10/18/2012US20120264790 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
10/18/2012US20120264777 Oxadiazole beta carboline derivatives as antidiabetic compounds
10/18/2012US20120264773 Organic compounds
10/18/2012US20120264756 Phosphatidylcholine Transfer Protein Inhibitors
10/18/2012US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
10/18/2012US20120264753 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same
10/18/2012US20120264748 Diaza-spiro[5.5]undecanes
10/18/2012US20120264747 Triazolopyridine jak inhibitor compounds and methods
10/18/2012US20120264743 Crystalline forms of (r)-8-chloro-1-methyl-2,3,4,5-thtrahydro-1h-3-benzazepine hydrochloride
10/18/2012US20120264740 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
10/18/2012US20120264725 Substituted porphyrins
10/18/2012US20120264721 Analogues of cilostazol
10/18/2012US20120264714 Boron-containing small molecules as anti-inflammatory agents
10/18/2012US20120264706 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
10/18/2012US20120264700 Glycoside derivatives and uses thereof
10/18/2012US20120264698 Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions
10/18/2012US20120264689 Methods and compositions for skin regeneration
10/18/2012US20120264685 Short chain peptidomimetics based orally active glp 1 agonist and glucagon receptor antagonist
10/18/2012US20120264684 Glycosylated Form of Antigenic GLP-1 Analogue
10/18/2012US20120264683 Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity
10/18/2012US20120264682 Tissue protective peptides and uses thereof
10/18/2012US20120264680 Regulation of energy metabolism and obesity by modulating b cell activating factor (baff, blys) or baff signaling
10/18/2012US20120264677 Oxidant resistant apolipoprotein a-1 and mimetic peptides
10/18/2012US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
10/18/2012US20120264674 Methods for preparing purified polypeptide compositions
10/18/2012US20120263808 Bioavailability enhancing compound
10/18/2012US20120263798 Body Aqua
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263786 Pharmaceutical Formulations Containing an SGLT2 Inhibitor
10/18/2012US20120263765 Agents from cells
10/18/2012US20120263762 Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate
10/18/2012US20120263733 Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inhibition of inflammation
10/18/2012US20120263718 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 1298